Researchers investigate how optical and proteomic abnormalities emerge during the earliest stages of tumor formation. The project focuses on detecting preclinical cancer signatures through integrated imaging and molecular profiling techniques.

The long-term objective is to enable earlier intervention strategies through highly sensitive diagnostic systems capable of identifying malignancy before conventional imaging reveals structural changes.